Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tzoar 207 Negative Pressure Wound Therapy (NPWT) System

K-Number: K202898 · 2021-12-30

Decision Date2021-12-30
Product CodeOMP
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Tzoar 207 Negative Pressure Wound Therapy (NPWT) System is a medical device manufactured by Lightstone Medical Products (Ningbo) Co, Ltd.. It received FDA 510(k) clearance on 2021-12-30 under approval number K202898. The device is classified under product code OMP. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tzoar 207 Negative Pressure Wound Therapy (NPWT) System?

Tzoar 207 Negative Pressure Wound Therapy (NPWT) System is a medical device that received FDA 510(k) clearance on 2021-12-30. It is manufactured by Lightstone Medical Products (Ningbo) Co, Ltd.. The 510(k) number is K202898.

When was Tzoar 207 Negative Pressure Wound Therapy (NPWT) System approved by the FDA?

Tzoar 207 Negative Pressure Wound Therapy (NPWT) System received FDA 510(k) clearance on 2021-12-30, under approval number K202898.

What company makes Tzoar 207 Negative Pressure Wound Therapy (NPWT) System?

Tzoar 207 Negative Pressure Wound Therapy (NPWT) System is manufactured by Lightstone Medical Products (Ningbo) Co, Ltd..

What is the FDA product code for Tzoar 207 Negative Pressure Wound Therapy (NPWT) System?

The FDA product code for Tzoar 207 Negative Pressure Wound Therapy (NPWT) System is OMP.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: OMP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.